Thomson Reuters/Uni...
Health Care: Drugs
Momenta Pharmaceuticals Inc. (MNTA: NASDAQ)
$13.03 -0.01 | -0.08%
05/17/13 - 04:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 13.03 |
| 52 Week High | 17.09 |
| 52 Week Low | 10.05 |
| Avg. Daily Vol. (Mil) | 0.31 |
| Beta (3 year) | 2.28 |
| Share Related Items | |
| Mkt Cap (Mil) | 676.58 |
| Shares Out (Mil) | 51.93 |
| Float (Mil) | 45.10 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 20.00 |
| Current Ratio | 21.00 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 14.31 |
| Price/Book | 1.99 |
| Price/Cash Flow | -10.20 |
| Per Share Data | |
| Earnings | -1.54 |
| Sales | 0.91 |
| Book Value | 6.55 |
| Cash Flow | -1.27 |
| Business Summary | |
|---|---|
| Momenta Pharmaceuticals, Inc., is a biotechnology company. It specializes in the structural characterization, process engineering and biologic systems analysis of complex molecules such as polysaccharides, polypeptides, and biologics. | |
| General Information | |
| 675 West Kendall Street
Cambridge, MA 02142 |
|
| www.momentapharma.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 247 | |
| CEO: Craig A. Wheeler | |
| Short Interest | |
| Current Month (Mil) | 2.78 |
| Previous Month (Mil) | 2.88 |
| Short Interest Ratio (Days) | 11.90 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -20.30 |
| Return on Investments | -22.00 |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
Portfolios with MNTA
- Portfolio NameUser Type
- UserSm. Magic July 5 13
- ProDiscovery Capital Management
- ContributorTop-Rated Biotechnology Stocks
- Contributor8 Pharma Stocks to Watch
- Contributor10 Stocks With Highest Prof...
- ContributorRelative Strength Stocks 09...
- UserMF
- ContributorEarnings Short Squeeze Play...
- ContributorBreakout Stocks Of The Week...
- Contributor4 Drug Stocks Poised to Sta...
Latest MNTA Headlines from TheStreet
- Momenta Pharmaceuticals (MNTA) Shares Cross Above 200 DMA 05.13.13 | 04:05 pm
- Momenta Pharmaceuticals To Webcast Presentations At Two Upcoming Investor Conferences 05.09.13 | 04:05 pm
- 5 Names Seeing Bullish Options Flow 05.02.13 | 12:05 pm
- Oversold Conditions For Momenta Pharmaceuticals (MNTA) 04.30.13 | 12:04 pm
- Momenta Pharmaceuticals Reports First Quarter 2013 Financial Results 04.30.13 | 08:04 am
- Momenta Pharmaceuticals Breaks Above 200-Day Moving Average - Bullish For MNTA 04.22.13 | 12:04 pm
- Momenta Pharmaceuticals Announces Date Of First Quarter 2013 Financial Results Conference Call And Webcast 04.09.13 | 04:04 pm
- Momenta Pharmaceuticals To Webcast Presentations At Two Upcoming Investor Conferences 02.25.13 | 04:02 pm
- Momenta Pharmaceuticals Reports Fourth Quarter And Year End 2012 Financial Results 02.15.13 | 08:02 am
- Momenta Pharmaceuticals To Webcast Presentations At Two Upcoming Investor Conferences 02.07.13 | 09:02 am
Press Releases for MNTA
- Baxter And Momenta Announce Collaboration To Develop And Commercialize Follow-On Biologics - Business Wire 12.22.11 | 04:12 pm
Partner Headlines for MNTA
- Pluristem Therapeutics' Answer To Big Pharma's Question: What Do We Do Now? - Seeking Alpha 07.18.12 | 09:07 am
- Company News for June 26, 2012 - Corporate Summary - Zacks 06.26.12 | 10:06 am
- Cemex RISES 7% to Lead These 2 NYSE Top Percentage Winners - Wall St. Cheat Sheet 06.26.12 | 09:06 am
- Teva Jumps, But Still Must Repair Its Chart Further - Investor's Business Daily 06.25.12 | 05:06 pm
- Stocks Open In The Red: Teva Pharmaceuticals Surges - Investor's Business Daily 06.25.12 | 10:06 am
- Morning Market Losers - Benzinga 06.25.12 | 09:06 am
- Healthcare Biz Recap: FDA PROBES Pfizer's New Drug, Ventrus Biosciences ABANDONS Treatment - Wall St. Cheat Sheet 06.25.12 | 07:06 am
- Zynga GROWS in Social Gaming Market and 4 Fresh Analyst Insights - Wall St. Cheat Sheet 06.25.12 | 05:06 am
- Analyst Insights: Molycorp, AeroVironment, Teradyne, Pfizer, Momenta Pharma May 29th - Wall St. Cheat Sheet 05.29.12 | 10:05 am
- Notable Options Activity in Momenta Pharmaceuticals Inc - Benzinga 04.19.12 | 12:04 pm
